Examkin

Soru

Zorluk: ZorPharmacologic Interventions

A 58-year-old man with a history of stage 4 chronic kidney disease and heart failure is brought to the emergency department due to profound generalized muscle weakness and palpitations that began earlier today. His medications include lisinopril and newly prescribed spironolactone. His heart rate is 54/min, and blood pressure is 112/68 mmHg. An electrocardiogram reveals widened QRS complexes merging with tall, peaked T waves in a "sine wave" pattern. A point-of-care basic metabolic panel shows a serum potassium level of 8.4 mEq/L.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute management of this patient's condition.

  1. 1Administer intravenous calcium gluconate
  2. 2Administer intravenous regular insulin and 50% dextrose
  3. 3Administer oral sodium zirconium cyclosilicate

Cevap

The correct sequence of administration is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and 50% dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental algorithm for severe hyperkalemia with electrocardiographic changes dictates a strict temporal sequence based on the onset of action of each pharmacologic agent. First, myocardial cell membranes must be stabilized to prevent lethal arrhythmias, which is achieved rapidly (1-3 minutes) with intravenous calcium gluconate. Second, potassium must be temporarily redistributed into the intracellular compartment using intravenous regular insulin (accompanied by dextrose to prevent hypoglycemia); this process takes 15-30 minutes. Finally, total body potassium must be definitively reduced using gastrointestinal potassium binders such as sodium zirconium cyclosilicate, which have an onset of several hours. Proceeding in any other order leaves the patient vulnerable to sudden cardiac death.

Adım Adım Çözüm

1
Identify the life-threatening emergency.
The patient has severe hyperkalemia (8.4 mEq/L) with critical ECG changes (widened QRS, sine wave pattern).
Recognizing sine wave morphology indicates impending cardiac arrest, necessitating immediate step-wise intervention.
2
Prioritize myocardial stabilization.
Select intravenous calcium gluconate as the immediate first intervention.
Calcium directly antagonizes the membrane actions of hyperkalemia. It restores the resting membrane potential difference, taking effect in 1-3 minutes to prevent fatal arrhythmias.
3
Initiate temporary potassium shifting.
Select intravenous regular insulin (with dextrose to prevent hypoglycemia) as the second intervention.
Once the heart is temporarily protected, serum potassium must be rapidly lowered. Insulin drives potassium into cells via Na+/K+-ATPase activation, acting within 15-30 minutes.
4
Establish definitive potassium removal.
Select oral sodium zirconium cyclosilicate as the final pharmacologic step in this sequence.
Calcium and insulin are temporary measures. A potassium binder removes total body potassium through the gastrointestinal tract, providing definitive but slower (hours) treatment.

Anahtar Kavram

The sequential management of severe hyperkalemia involves three distinct phases: immediate myocardial stabilization (calcium), rapid intracellular shifting (insulin/glucose), and definitive total body removal (cation exchange resins or loop diuretics).
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru